Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifamurtide in Pgp-positive Osteosarcoma (ISG/OS-2)
NCT01459484Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- Jun 2011
- Primary completion
- Apr 2024
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of mifamurtide in osteosarcoma (OS), sponsored by Italian Sarcoma Group. Started Jun 2011; status: completed.
02
Drugs
mifamurtide
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT01459484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01459484.